News Posts List
Renal Cell Carcinoma Epidemiology
06/03/2010
In Europe the incidence of RCC has doubled in the period from 1975 to 2005. RCC accounted for 3777 deaths in the UK in 2006; male 2372, female 1820.
Renal Cell Carcinoma Treatments
06/03/2010
If it is only in the kidneys, which is about 40% of cases, Renal Cell Carcinoma (RCC) can be cured roughly 90% of the time with surgery.
Renal Cell Carcinoma Survival Rate
06/03/2010
If it has metastasized to the lymph nodes, the 5-year survival is around 5 % to 15 %. If it has spread...to other organs, the 5-year survival rate is less than 5 %.
Adjuvant Therapy in Renal Cell Carcinoma
06/03/2010
There is currently no established adjuvant therapy for renal cell carcinoma, although there have been a number of clinical trials exploring the effectiveness of various potential treatments.
Metastatic Renal Cell Carcinoma
06/03/2010
Currently, tumor vaccines and chemotheraputic, biologic, and immunologic agents are being researched in the treatment of metastatic renal cell carcinoma, and some appear promising.
A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
06/03/2010
"Several therapies have been introduced in the past few years that have led to improvements in the way we treat advanced kidney cancer," says Joseph S. Camardo, M.D., Senior Vice President, Global Medical Affairs, Wyeth Pharmaceuticals. "In the INTORACT study, we hope to learn more about whether combining TORISEL with other agents in the first-line setting may further improve outcomes for patients with this devastating disease."
Radiofrequency Ablation as Effective as Traditional Surgery in Treating Renal Cancer
06/03/2010
Radiofrequency ablation (RFA) showed similar effectiveness as surgical removal of renal tumours in curbing cancer recurrence rates for up to 5 years after treatment, according to a study published online in the journal Cancer.
Fox Chase Researchers Present At American Urological Association
06/03/2010
Fox Chase Cancer Center researchers presented three abstracts at the 2010 annual meeting of the American Urological Association (AUA) that demonstrate progress in the use of the R.E.N.A.L. Nephrometry Scoring to characterize renal mass anatomy and allow standardization of surgical decision-making and comparison of outcomes in patients with kidney cancers.
Significant overall survival advantage for RCC patients treated with autologous tumor lysate vaccine
06/03/2010
Advances in nephron-sparing surgery, laparoscopic approaches, and novel targeted therapies have dramatically improved the outcomes for patients with renal-cell carcinoma. Despite these advances, adjuvant treatment options following surgery are needed, and one approach that was shown to be successful in a previous multicenter phase III trial was an autologous tumor-based vaccine.
"Advances in Renal Cancer" Journalists' Award 2011 announced
06/01/2010
Bayer HealthCare and Kidney Cancer Association (KCA) honor medical reporting about renal cancer
News Feed